-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Lars Klingen Gjaerde, MD1*, Sisse Rye Ostrowski, MD, PhD, DMSc, Prof2*, Frederikke Schierbeck, MD1*, Niels Smedegaard Andersen, MD, DMSc3*, Lone Smidstrup Friis, MD, PhD3*, Brian Thomas Kornblit, MD, PhD1*, Søren Lykke Petersen, MD, DMSc3*, Ida Schjødt, MD, PhD3* and Henrik Sengeloev, MD, DMSc, Prof3*

1Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
2Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
3Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Xavier Poiré, MD, PhD1*, Myriam Labopin2,3*, Emmanuelle Polge, M.Sc4*, Arnold Ganser, MD5, Gerard Socie, M.D.6,7, Tobias Gedde-Dahl8*, Edouard Forcade, MD, PhD9, Jürgen Finke Sr., MD, PhD10, Yves Chalandon, MD11, Claude-Eric Bulabois, MD12*, Ibrahim Yakoub-Agha13, Mahmoud Aljurf14, Nicolaus Kröger, MD15*, Igor Wolfgang Blau, MD16*, Arnon Nagler, MD3,17, Jordi Esteve, MD, PhD18 and Mohamad Mohty, MD, PhD19,20

1Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
2EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3Acute Leukemia Working Party of EBMT, Paris, France
4ALWP of the EBMT Paris office, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
5Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
6Hopital St. Louis, Dept.of Hematology – BMT, Paris, France
7Assistance Publique Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France
8Oslo University Hospital, Oslo, Norway
9Service d’hematologie et thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France
10Department of Medicine I, University Medical Center Freiburg, Freiburg, Germany
11Geneva University Hospitals, Geneva, Switzerland
12Service d'Hematologie, CHU Grenoble Alpes-Universite Grenoble Alpes, Grenoble, France
13Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France
14Oncology, Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
15Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
16Department of Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
17Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
18Hospital Clínic, Barcelona, Spain
19Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Paris, France
20Acute Leukemia Working Party, Paris Study office, European Society for Blood and Marrow Transplantation, Paris, France

Xavier Poiré, MD, PhD1*, Diderik-jan Eikeman2*, Linda Koster3*, Johan A. Maertens, MD, PhD4*, Jan J. Cornelissen, MD, PhD5, Nathalie Fegueux, MD6*, Jennifer Byrne7*, Urpu Salmenniemi, MD8*, Goda Choi, MD PhD MBA9, Patrice Chevallier, MD10, Francesca A Kinsella, PhD, MRCP11*, Thomas Schroeder, MD12*, Yves Beguin, MD, PhD13, Didier Blaise14, Jean-Henri Bourhis, M.D.15, Jurgen H.E. Kuball, MD, PhD16, Hendrik Veelken, MD, PhD17, Jakob R. Passweg, MD, MS18, Arancha Bermudez Rodriguez, MD19*, Micha Srour, MD20*, Patrick John Hayden, MD21, Francesco Onida, MD22, Christof Scheid23, Marie Robin, MD, PhD24 and Ibrahim Yakoub-Agha25

1Section of Hematology, Cliniques Universitaires St-Luc, Brussels, Brussels, Belgium
2EBMT Statistical Unit, Leiden, Netherlands
3EBMT Data Office, Leiden, Netherlands
4Deptartment of Hematology, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium
5Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
6Département d’Hématologie Clinique, CHU Lapeyronie Montpellier, Montpellier, France
7Centre for Clinical Haematology, Nottingham University, Nottingham, ENG, United Kingdom
8Stem Cell Transplantation Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
9Dept. of Hematology, University Medical Center Groningen (UMCG),University of Groningen, Groningen, Netherlands
10Hematology, Hôpital Hôtel Dieu, Nantes, France
11Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, ENG, United Kingdom
12Hematology, Uniklinik Dusseldorf, Duesseldorf, Germany
13Department of Hematology, CHU Liege, University of Liege, Liege, Belgium
14Department of Hematology, Institut Paoli Calmettes, Marseille, France
15Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
16Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
17Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
18Hematology, University Hospital Basel, Basel, Switzerland
19Servicio de Hematología-Hemoterapia, Hospital U. Marqués de Valdecilla, Santander, Spain
20Hematologie CHRU de Lille, Lille, France
21Department of Haematology, Trinity College Dublin, St.James Hospital, Foxrock, Dublin, Ireland
22Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
23University of Cologne, Cologne, Germany
24Hopital Saint-Louis, Paris Cedex 10, France
25Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France

Guillermo Ortí, MD, PhD1*, Luuk Gras Sr.2*, Nienke Zinger3*, Aleksandr D. Kulagin4*, Jennifer Byrne5*, Jane F Apperley, FRCP, FRCPath, MB 6, Kazimierz Halaburda7*, Igor Wolfgang Blau, MD8*, Andrew Clark9*, Nicolaus Kröger, MD10*, Laimonas Griskevicius11*, Kristina Carlson, MD, PhD12, Matthew P. Collin, MD, PhD13,14, Adrian Bloor, MD, PhD, FRCP, FRCPath15*, Emanuele Angelucci16, Didier Blaise17, Mahmoud Aljurf18, Lucia Lopez Corral, MD, PhD19*, Achilles Anagnostopoulos20, Yves Beguin, MD, PhD21, Tomasz Wrobel, MD, PhD22, Luigi Rigacci, lrigacci@scamilloforlanini.rm.it23*, Patrick John Hayden, MD24, Yves Chalandon, MD25 and Ibrahim Yakoub-Agha26

1Hospital Universitari Vall d’Hebron, Barcelona, Spain
2EBMT Statistical Unit, Leiden, Netherlands
3EBMT Data Office, Leiden, Netherlands
4Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, First Pavlov State Medical University of St. Petersburg, St Petersburg, Russian Federation
5Nottingham City Hospital, Nottingham, United Kingdom
6Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College, London, ENG, United Kingdom
7Institute of Hematology and Transfusion Medicine, Warsaw, Poland
8Department of Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
9Beatson , West of Scotland Cancer Centre, Glasgow, GBR
10University Hospital Eppendorf, Hamburg, Germany
11Vilnius University Hospital Santariskiu Clinics, Vilnius, Na, LTU
12Uppsala University Hospital, Uppsala, Uppsala Laen, Sweden
13Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, UK, Newcastle Upon Tyne, United Kingdom
14Adult HSCT unit, Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, United Kingdom
15Adult Leukaemia and Bone Marrow Transplant Unit, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, United Kingdom
16Department of Hematology II, San Martino University Hospital, Genoa, Italy
17Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France
18Oncology, Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
19Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain
20Hematology Department – HCT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
21CHU de Liège, University of Liège, Liege, Belgium
22Wrocław Medical University, Wrocław, Poland
23Dept. of hematology and BMT, Ospedale S. Camillo-Forlanini, Roma, Italy
24Department of Haematology, Trinity College Dublin, St.James Hospital, Foxrock, Dublin, Ireland
25Geneva University Hospitals, Geneva, Switzerland
26Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France

Ibrahim Aldoss, MD1, Dongyun Yang, PhD2*, Zhaohui Gu, PhD2, Vanina Tomazian3*, Sally Mokhtari4, Ryan Jackson3*, Milhan Telatar, PhD3*, Hooi Yew, PhD3*, MHD Monzr M. Al Malki, MD5, Amandeep Salhotra, MD1, Samer Khaled6*, Haris Ali, MD1, Ahmed Aribi, MD1, Karamjeet S. Sandhu, MD 1, Matthew Mei, MD1, Shukaib Arslan, MD1, Paul Koller, MD1, Andrew S. Artz, MD, MS5, Patricia Aoun, MD1*, Dongqing Gu3*, David S Snyder, MD1, F. Mark Stewart, MD1*, Peter T. Curtin, MD1, Anthony S. Stein, MD1, Raju Pillai, MD3*, Guido Marcucci, MD1, Stephen J Forman, MD1, Vinod A. Pullarkat, MD1, Ryotaro Nakamura, MD1 and Michelle Afkhami, MD3*

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Department of Pathology, City of Hope National Medical Center, Duarte, CA
4Department of Clinical Translational Program Development, City of Hope National Medical Center, Duarte, CA
5Department of Hematology/HCT, City of Hope, Duarte, CA
6Janssen Research & Development, Los Angeles, CA

Claudio G. Brunstein, MD, PhD1, Paul V O’Donnell, MD2*, Brent R. Logan, PhD3*, Luciano J. Costa, MD, PhD4, Corey Cutler, MD, MPH, FRCPC5, Michael Craig, MD6, William J Hogan, MB, BCh7, Mary M. Horowitz, MD, MS3, Mitchell E. Horwitz, MD8, Chatchada Karanes, MD9, John M. Magenau, MD10, Adriana Malone, MD11*, John M McCarty, MD12*, Joseph P. McGuirk, DO13, Lawrence E Morris, MD14, Andrew R. Rezvani, MD15, Witold Rybka16*, Rachel Beth Salit, MD17*, Sumithira Vasu, MBBS18, Mary Eapen, MBBS, MS19 and Ephraim J. Fuchs, MD, MBA20

1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
2Massachusetts General Hospital, Boston
3Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
4University of Alabama at Birmingham, Vestavia, AL
5Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA
6WVU Cancer Institute, West Virginia University, Morgantown, WV
7Division of Hematology, Mayo Clinic, Rochester, MN
8Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
9Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
10Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
11Mount Sinai, New York City
12Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program, Richmond, VA
13Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
14Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA
15Division of BMT and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
16Penn State Cancer Institute, Hershey, PA
17Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
18Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
19Medical College of Wisconsin, Milwaukee, WI
20Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Amanda C. Winters, MD, PhD1, Grace Bosma2*, Diana Abbott, PhD3*, Mohd Minhajuddin, PhD4, Craig T Jordan, PhD5, Daniel A. Pollyea, MD, MS6* and Jonathan A. Gutman, MD7

1Department of Pediatrics, University of Colorado, Aurora, CO
2Department of Biostatistics and Bioinformatics, University of Colorado Anschutz Medical Campus, Aurora, CO
3Department of Biostatistics and Bioinformatics, University of Colorado Denver, Colorado Springs, CO
4Anschutz Medical Campus, Division of Hematology, University of Colorado, Aurora, CO
5Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO
6Department of Hematology, University of Colorado, Aurora, CO
7Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical School, Aurora, CO

Jacinta Perram, MBBS1,2, Eleni Mayson, MBBS (Hons), BSc(Med), FRACP, FRCPA, MPhil(Med)1,2*, Catherine Tang, MBBS, BSc, FRACP, FRCPA3, Steven Tran, BEng, MBiomedE4*, Donna Aarons, BPharm4*, Anthony J Dodds, MBBS, FRACP, FRCPA1, Keith Fay, MBChB, FRCPA, FRACP1,3*, Nada Hamad2,5,6, David Ma, MBBS, PhD, FRACP, FRCPA1,2*, Sam Milliken, MBBS, FRACP, FRCPA1,2*, Barbara Withers, MBBS, BSc, PhD, FRACP, FRCPA1,2*, Matthew Greenwood, MBBS, FRACP, FRCPA3,7*, William S Stevenson, MBBS, PhD, FRACP, FRCPA3, Christopher Kevin Arthur, MBBS, FRACP, FRCPA3,7, Ian H Kerridge, BA, BMed(Hons), MPhil(Cantab), FRACP, FRCPA3,7* and John Moore, MD, FRACP, FRCPA1,2*

1Department of Haematology and Bone Marrow Transplant, St Vincent's Hospital, Sydney, NSW, Australia
2St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia
3Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
4The Australasian Bone Marrow Transplant Recipient Registry, Sydney, NSW, Australia
5Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
6School of Medicine, University of Notre Dame, Sydney, NSW, Australia
7University of Sydney, Sydney, NSW, Australia

Francesco Onida, MD1, Ge Junran2*, Linda Koster3*, Rose-Marie Hamladji, MD, PhD4*, Jennifer Byrne5*, Victoria Potter, MBBS, BSc, FRACP, FRCPA6*, Mahmoud Aljurf7, Marie Robin, MD, PhD8, Kazimierz Halaburda9,10,11*, Jakob R. Passweg, MD, MS12, Urpu Salmenniemi, MD13*, Henrik Sengeloev, MD, DMSc, Prof14*, Jane F Apperley, FRCP, FRCPath, MB 15, Andrew Clark16*, Péter Reményi17*, Elena V. Morozova18*, Charles Craddock, FRCP, FRCPath19, Stig Lenhoff20*, Arnold Ganser, MD21, Ka Lung Wu, MD22, Antonio Perez Martinez23*, Patrick John Hayden, MD24, Luuk Gras Sr.25*, Yves Chalandon, MD26 and Ibrahim Yakoub-Agha27

1BMT Center - Hematology Unit, IRCCS Ospedale Maggiore Policlinico Di Milano-University of Milan, Milano, Italy
2University of Leiden, Leiden, Netherlands
3EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands
4Centre Pierre et Marie Curie, Alger, Algeria
5Centre for Clinical Haematology, Nottingham University, Nottingham, ENG, United Kingdom
6King's College Hospital NHS Foundation Trust, London, United Kingdom
7Oncology, Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
8Hopital Saint-Louis, Paris Cedex 10, France
9Institute of Hematology and Transfusion Medicine, Warsaw, Poland
109Institute of Hematology and Transfusion Medicine, Warsaw, Poland
11University Hospital, Warsaw, Poland
12Hematology, University Hospital Basel, Basel, Switzerland
13Stem Cell Transplantation Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
14Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
15Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom
16Beatson , West of Scotland Cancer Centre, Glasgow, GBR
17Dept. Haematology and Stem Cell Transplant, Albert, Dél-pesti Centrumkórház –Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary
18RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
19Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, ENG, United Kingdom
20Skanes University Hospital, Lund, Sweden
21Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
22ZNA, Antwerp, Belgium
23Hospital Infantil Universitario Niño Jesús, Madrid, ESP
24Department of Haematology, Trinity College Dublin, St.James Hospital, Foxrock, Dublin, Ireland
25EBMT Statistical Unit, Leiden, Netherlands
26Hematology, Geneva University Hospitals, Geneva, Switzerland
27Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, Lille, France

Charles Gaulin, MBBS1*, Blake T. Langlais, MS2*, Luke Mountjoy, DO3, Panagiotis Korfiatis, PhD4*, Nelly Tan, MD5*, Jose F. Leis, MD, PhD1, Nandita Khera, MD1, Pierre Noel, MD1, Lisa Z. Sproat, MD1, Tania Jain, MD6 and Jeanne M. Palmer, MD1

1Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
2Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
3Hematology Department, Colorado Blood Cancer Institute, Denver, CO
4Department of Radiology, Mayo Clinic, Rochester, MN
5Department of Radiology, Mayo Clinic, Phoenix, AZ
6Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Moazzam Shahzad, MD1,2*, Muhammad Salman Faisal, MD3, Ezza Tariq, MD2*, Ali Hussain, MD2*, Muhammad Arslan, MD2*, Venkata Thammineni, MD2, Leena Syed, MBBS2*, Alvina Karam, MBBS2*, Iqra Anwar, MBBS2*, Sibgha Gull Chaudhary, MD2*, Nausheen Ahmed, MBBS2, Tara L. Lin, MD4, Sunil Abhyankar, MD2, Peiman Hematti, MD5, Joseph P. McGuirk, DO2 and Muhammad Umair Mushtaq, MD2

1Internal Medicine, St. Mary's Medical Center, Barboursville, WV
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Roswell Park Cancer Center, Buffalo, NY
4Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
5Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI

Oren Pasvolsky, MD1,2*, Shai Shimony, MD1,2*, Ron Ram, MD3,4*, Avichai Shimoni, MD1,5*, Liat Shargian-Alon, MD1,6*, Batia Avni, MD7,8*, Ofir Wolach, MD9,10*, Tzippy Shochat11*, Ronit Yerushalmi, MD12,13, Odelia Amit, MBBS, BSc1,14*, Pia Raanani, MD1,15 and Moshe Yeshurun, MD1,6*

1Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
3BMT Unit, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
4Sackler Faculty of Medicine, Tel Aviv, Israel
5Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat-Gan, Israel
6Institute of Hematology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Petach Tikva, Israel
7Institute of Hematology,, Hadassah Medical Center, Jerusalem, Israel
8Department of Bone Marrow Transplantation, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
9The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
10Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel
11Biostatistical Unit, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel
12Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
13Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
14BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
15Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah –Tikva, Israel

Qamar Iqbal, MD1,2*, Moazzam Shahzad, MD2,3*, Ezza Tariq, MD2*, Laila Hashim, MBBS4*, Abdul Basit, MD5*, Kashf Zaidi4*, Muhammad Salman Faisal, MD4, Iqra Anwar, MBBS2*, Sibgha Gull Chaudhary, MD2*, Ramesh Balusu, PhD6, Nausheen Ahmed, MBBS2, Leyla Shune, MD7, Peiman Hematti, MD8,9, Joseph P. McGuirk, DO2 and Muhammad Umair Mushtaq, MD2

1Salisbury, MD
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Internal Medicine, St. Mary's Medical Center, Barboursville, WV
4University of Kansas Medical Center, Kansas
5University of Kansas Medical Center, kansas
6Division of Hematologic Maligancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
7Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
8Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI
9St Mary's, Huntington

Arnon Nagler, MD1, Myriam Labopin2*, Jan J. Cornelissen, MD, PhD3, Edouard Forcade, MD, PhD4, Patrice Chevallier, MD5, Nathalie Fegueux, MD6*, Jorge Sierra, MD7, Hélène Labussière-Wallet8*, Jennifer Byrne9*, Thomas Cluzeau, MD, PhD10,11, Didier Blaise12, Frédéric Baron, MD, PhD13, Annalisa Ruggeri, MD-PhD14*, Mohamad Mohty, MD, PhD15 and Deborah Desmier, MD16*

1Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat-Gan, Israel
2EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
4CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France, Pessac, France
5D'Hematologie, Nantes University Hospital, Nantes, France
6Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
7Hematology Department, Hospital Santa Creu Sant Pau, Barcelona, Spain
8Service Hematologie, Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard -Bat 1G, Lyon, France
9Centre for Clinical Haematology, Nottingham University, Nottingham, ENG, United Kingdom
10Department of Clinical Hematology, CHU De Nice, Nice, France
11Hematology department, Cote D'Azur University, CHU of Nice, Nice, France
12Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France
13Hematology Department, CHU and University of Liège, Liège, Belgium
14Ospedale San Raffaele s.r.l., Haematology and BMT, Milan, Italy
15Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Paris, France
16Hematology and cellular therapy department, University Hospital of Poitiers, Poitiers, FRA

Ayako Arai, MD, PhD1,2, Masahide Yamamoto, MD, PhD3*, Maho Sato, MD4*, Yasushi Onishi, MD, PhD5*, Yoji Sasahara, MD, PhD6,7, Hideki Sano, MD8*, Masayoshi Masuko, MD, Ph.D9, Hirohisa Nakamae, MD, PhD10*, Ken-Ichi Matsuoka11, Takahide Ara, MD, PhD12*, Kana Washio, M.D., Ph.D.13*, Makoto Onizuka, MD, PhD14, Kenichiro Watanabe, MD, PhD15*, Tsuneaki Hirakawa, MD, PhD16*, Miwako Nishio, PhD17*, Chizuko Sakashita, MD, PhD3*, Tohru Kobayashi, MD, PhD18*, Akihisa Sawada, MD, PhD4*, Tatsuo Ichinohe, MD, PhD19, Takahiro Fukuda20*, Yoshiko Hashii, MD, PhD21 and Yoshiko Atsuta, MD, PhD22,23*

1Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki-Shi, Japan
2Department of Hematological therapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
3Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
4Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan
5Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
6Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Japan
7Department of Pediatrics, Tohoku University Hospital, Sendai, Japan
8Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan
9Division of Stem Cell Transplantation, Niigata Univ. Med. Hosp., Niigata, Japan
10Department of Hematology, Osaka City University Hospital, Osaka, Japan
11Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
12Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
13Department of Pediatrics, Okayama University Hospital, Okayama, Japan
14Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
15Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan
16Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan
17Department of Laboratory Molecular Genetics of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
18Department of Management and Strategy, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan
19Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
20Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
21Cancer Immunotherapy/Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
22Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
23Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan

*signifies non-member of ASH